Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Apraclonidine hydrochloride |
Is a |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
Guanfacine (substance) |
Is a |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
Guanabenz (substance) |
Is a |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
Methyldopa (substance) |
Is a |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
clonidinhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
forgiftning med central alfa-adrenoceptoragonist |
Causative agent |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
1 |
Accidental clonidine poisoning |
Causative agent |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
Intentional clonidine poisoning |
Causative agent |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
forgiftning med clonidin, uvist med hvilken hensigt |
Causative agent |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
bivirkning af central alfa-adrenoceptor agonist |
Causative agent |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
Apraclonidine adverse reaction |
Causative agent |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
Clonidine adverse reaction |
Causative agent |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
Lofexidine adverse reaction |
Causative agent |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
allergi over for central alfa-adrenoceptoragonist |
Causative agent |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
Allergy to apraclonidine (finding) |
Causative agent |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
Allergy to clonidine (finding) |
Causative agent |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
Allergy to lofexidine (finding) |
Causative agent |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
overdosis af central alfa-adrenoceptor-agonist |
Causative agent |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
1 |
Clonidine overdose |
Causative agent |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
Accidental clonidine overdose |
Causative agent |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
Intentional clonidine overdose |
Causative agent |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
overdosis af clonidin, uvist med hvilken hensigt |
Causative agent |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
Clonidine hydrochloride [antihypertensive] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
clonidinhydrochlorid kapsel med modificeret udløsning a 250 µg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
clonidinhydrochlorid 150 µg/ml injektionsvæske, opløsning, ampul a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
Clonidine HCl [migraine] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
Product containing precisely clonidine hydrochloride 25 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
Lofexidine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
Lofexidine hydrochloride 200 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
Product containing apraclonidine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
central alfa-receptor-agonist |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
1 |
Product containing lofexidine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
Clonidine hydrochloride 0.1mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
Clonidine hydrochloride 200 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
Clonidine hydrochloride 0.3mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
clonidin 2,5 mg/enhed |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
clonidin 7,5 mg/enhed |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
Clonidine hydrochloride 100mcg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
clonidin 4 mg plaster |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
clonidin 0,1 mg plaster |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
clonidin 5 mg plaster |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
Chlortalidone 15 mg and clonidine hydrochloride 200 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
Product containing precisely chlortalidone 15 milligram and clonidine hydrochloride 300 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
Clonidine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
Clonidine-containing product in transdermal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
Product containing clonidine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
Clonidine m/r |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
Poisoning by clonidine |
Causative agent |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
Product containing clonidine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
Apraclonidine hydrochloride 1%/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
Apraclonidine hydrochloride 0.5% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
chlortalidon + clonidinhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
clonidinhydrochlorid 100 µg/ml injektionsvæske, opløsning, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
Clonidine hydrochloride 100 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
Product containing precisely clonidine hydrochloride 300 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
Apraclonidine (as apraclonidine hydrochloride) 5 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
apraclonidin 1% intraokulær opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
apraclonidinhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
clonidinhydrochlorid 0,5 mg/ml injektionsvæske, opløsning, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
Clonidine (substance) |
Is a |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
Lofexidine (substance) |
Is a |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
allergi over for central alfa-adrenoceptoragonist |
Causative agent |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
1 |
Lofexidine hydrochloride (substance) |
Is a |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
Clonidine hydrochloride (substance) |
Is a |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
Methyldopa anhydrous |
Is a |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
Guanfacine hydrochloride |
Is a |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|
Guanabenz acetate |
Is a |
False |
Central alfa-adrenoreceptoragonist |
Inferred relationship |
Some |
|